Wang Yen Po (Peter) Was Recognized With The “Outstanding Leadership Award” At The Health 2.0 Conference, Winter Edition, Dubai 2022
Dubai, UAE — December 20, 2022 — Wang Yen Po (Peter) was honored with the “Outstanding Leadership Award” for his extraordinary achievements in the field of healthcare at the Winter Edition of the Health 2.0 Conference, held at the InterContinental, Dubai Festival City, UAE on December 16–18, 2022.
Yen Po Wang is the Co-founder and CTO at INOPASE. Inc. The company is developing the world’s first less invasive closed-loop neuromodulation focusing on neural function restoration treatment, such as urinary incontinence, epilepsy, etc. Yen is always keen to look for innovation and business collaboration. He also serves as Asia Pacific Business Expansion Project Lead at BE Health Ventures, Taiwan’s most prominent healthcare venture capital firm. His team created a bridge to help international companies to access hospital resources for quick proof-of-concept validation and market access in Japan, China, and Taiwan.
Owing to his extraordinary profile and significant contributions to the healthcare sector, Wang Yen Po is the ideal candidate to receive awards and appreciation.
A three-day event, the Health 2.0 Conference promotes collaboration and knowledge sharing and spotlights the industry-leading work of trailblazing individuals and organizations. The conference’s Dubai Edition aimed to provide a platform for healthcare leaders with motivational stories, diversified experiences, and valuable viewpoints to share while promoting peer networking and potential collaborations. Refer to this link to get more information about its upcoming events: www.health2conf.com.
Contact Details:
Bhawna Banga
+1 (323) 536–8480
pr@health2conf.com
